INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/27/2026
Back to search
Official data from USPTO
CELLHESION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELLHESION
ST13
US500000079237778Class
1, 5
Filing
79237778
Registration
5772148
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
04/28/2026
Trademark type
Word
Nice classes
1, 5
Filing date
12/07/2017
Registration date
06/11/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2025
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Chuo-kuTokyo 103-6119, JP
Examiner
MORENO, PAUL A
Current location
Historical data usage
Holders and representatives
Holders
N. C. (pessoa física)
Representatives
Ee Ming T. Bahk Oliff PLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and sciencechemical media additives; chemical preparations for use in industrychemical media additives; chemical preparations for scientific purposeschemical media additives; chemical media additivesother than for medical or veterinary purposes; chemical media additives in kit formother than for medical or veterinary purposes; chemical media additives for scientific or research purposesother than for medical or veterinary purposes; chemical media additives in kit form for scientific or research purposesother than for medical or veterinary purposes; chemical media additives for cell cultureother than for medical or veterinary purposes; chemical media additives for tissue cultureother than for medical or veterinary purposes; chemical media additives for culture of microorganismsother than for medical or veterinary purposes; media for cell culture for scientific or research purposesother than for medical or veterinary purposes; media for tissue culture for scientific or research purposesother than for medical or veterinary purposes; media for culture of microorganisms for scientific or research purposesother than for medical or veterinary purposes; media for three-dimensional cell culture for scientific or research purposesother than for medical or veterinary purposes; media for three-dimensional tissue culture for scientific or research purposesother than for medical or veterinary purposes; media for three- dimensional culture of microorganisms for scientific or research purposesother than for medical or veterinary purposes; media for cell culturing for laboratory use; dispersing agents; chemical media additives for use in separation of cellsother than for medical or veterinary purposes; media for cell culture in kit form for scientific or research purposesother than for medical or veterinary purposes; media for tissue culture in kit form for scientific or research purposesother than for medical or veterinary purposes; media for culture of microorganisms in kit form for scientific or research purposesother than for medical or veterinary purposes; all of the above not including reagents and diagnostic materials
Class 5
Pharmaceutical preparations for use in regenerative medicineoncology and hematology; pharmaceutical preparations for the treatment of viral and infectious diseasesautoimmune diseaseskidney diseaseshepatic diseasesneurological diseases and bone diseases; chemical media additives for medical or veterinary purposes; chemical media additives in kit form for medical or veterinary purposes; chemical media additives for cell culturefor medical or veterinary purposes; chemical media additives for tissue culturefor medical or veterinary purposes; chemical media additives for culture of microorganismsfor medical or veterinary purposes; culture media for use in regenerative medicineoncologyhepatology and hematology; culture media for augmentation of bone and other tissues for medical purpose using iPS/ES cells and other stem cells; culture media for use to produce biomedicinein particular antibody medicines and vaccine medicines; culture media of microorganisms for medical use; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; all of the above not including reagents and diagnostic materials
Publications
History of USPTO decisions and trademark events.
39 publications found
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
08/27/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
08/27/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/25/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
05/28/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/12/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/11/2024
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
10/25/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/05/2019
FIMP
FINAL DISPOSITION PROCESSED
10/05/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2019
PUBO
PUBLISHED FOR OPPOSITION
03/26/2019
GPNX
NOTIFICATION PROCESSED BY IB
03/23/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/06/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/19/2019
ALIE
ASSIGNED TO LIE
02/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/13/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/30/2018
GNRT
NON-FINAL ACTION E-MAILED
11/30/2018
CNRT
NON-FINAL ACTION WRITTEN
11/30/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/26/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/26/2018
RFNT
REFUSAL PROCESSED BY IB
09/21/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/05/2018
RFRR
REFUSAL PROCESSED BY MPU
09/05/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/21/2018
CNRT
NON-FINAL ACTION WRITTEN
08/20/2018
MAFR
APPLICATION FILING RECEIPT MAILED
08/10/2018
DOCK
ASSIGNED TO EXAMINER
08/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/03/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/02/2018
Continuous trademark protection
Get notified about every new filing that threatens CELLHESION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.